Delivery Order SPE2DR25D1109-SPE2DR26FFJ2X
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 tablets per unit. This competitively awarded, non-set-aside contract carries a firm fixed price ceiling value of $2,662.07 and is scheduled for completion by July 23, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. This firm fixed price delivery order, valued at $8,141.67, represents a non-competitive set-aside procurement and is scheduled for ultimate completion by August 1, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $5,831.62 delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of XELJANZ XR 11 MG tablets in quantities of 30 units. This competitive, firm fixed-price contract carries an ultimate completion date of December 18, 2025, with no set-aside designation. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and a critical distribution hub for...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $11,203.83 firm fixed price delivery order on December 3, 2025, for XELJANZ XR 11 mg tablets (30-count units) with an ultimate completion date of December 4, 2025. This non-set-aside competitive award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XELJANZ XR 11 MG tablets (30-count units) on November 7, 2025, with a ceiling value of $11,895.83 and firm fixed pricing. The award is non-competitive and represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle valued through December 2026. AmerisourceBergen,...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. This is a firm fixed price delivery order valued at $25,624.50, with performance completion scheduled for September 15, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and represents a competitively...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $4,091.04 on November 25, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, completed competitively through open procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 26, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $25,621.47 and an ultimate completion date of August 14, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. This firm fixed price, non-set-aside delivery order has a ceiling value of $9,808.70 and is scheduled for completion by November 26, 2025. The order is fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical...
- The Defense Logistics Agency awarded a $17,639.67 delivery order to AmerisourceBergen Drug Corp for XELJANZ XR 11 mg tablets (30-count units) on November 5, 2025, with completion scheduled for November 6, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is listed...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFJ2XDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $9,231.20 and a completion date of December 19, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award represents a non-competitive delivery order issued under AmerisourceBergen's broader indefinite delivery contract with DLA Troop Support Medical, a $1 billion prime vendor agreement (SPE2DX) that extends through December 2026 and serves as the primary vehicle for global pharmaceutical and medical supply support to military healthcare systems worldwide. As a child order under the larger IDC, this delivery order fulfills specific pharmaceutical needs within the Defense Health Agency's medical supply chain. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor supplying brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. The company maintains an extensive track record of competitively awarded contracts with DLA and regularly supplies specialty medications to support military healthcare programs globally, demonstrating its capability to meet federal procurement requirements for time-sensitive pharmaceutical deliveries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 12/17/25 |